Table 2 GLM Coefficients for the different models (Mean ± SD) for predicting lesion development
From: Evaluating effects of normobaric oxygen therapy in acute stroke with MRI-based predictive models
Models | Bias | T2WI | ADC | iDWI | CBF | CBV | MTT | Tmax |
|---|---|---|---|---|---|---|---|---|
Models Predicting 4 h Lesion Development (during treatment) | ||||||||
Control | -11 ± 1.4§ | 4.0 ± 1.0§ | -4.3 ± 1.3§ | 9.3 ± 1.2§ | -0.9 ± 0.2 | 0.7 ± 0.1 | 0.5 ± 0.2 | 0.07 ± 0.008§ |
NBO | -17 ± 0.8§ | 2.0 ± 0.3§ | 0.10 ± 0.3*§ | 11 ± 0.5§ | -0.4 ± 0.2*§ | -0.02 ± 0.2* | 0.9 ± 0.2 | 0.05 ± 0.008§ |
Models Predicting 24 h Lesion Development (post-treatment) | ||||||||
Control | -3.1 ± 1.0†| 8.1 ± 0.8†| -9.1 ± 1.0†| 2.3 ± 0.8†| -0.7 ± 0.1 | 0.5 ± 0.1 | 0.5 ± 0.1 | 0.05 ± 0.007†|
NBO | -13 ± 0.5†| 0.6 ± 0.2†| 1.0 ± 0.2†| 8.9 ± 0.3†| 0.2 ± 0.09†| -0.2 ± 0.08 | 1.3 ± 0.1 | 0.1 ± 0.006†|
Models Predicting Discharge Lesion Development | ||||||||
Control | -3.4 ± 0.6†| 4.2 ± 0.4§ | -5.1 ± 0.5§ | 2.7 ± 0.5†| -0.7 ± 0.1 | 0.5 ± 0.08 | 0.9 ± 0.1§†| 0.06 ± 0.006 |
NBO | -8.8 ± 0.3†§ | 0.3 ± 0.1†| 0.7 ± 0.2 | 6.1 ± 0.2†§ | -0.2 ± 0.09*§ | -0.06 ± 0.07* | 0.9 ± 0.09§ | 0.1 ± 0.006†|